Calculate target mg/mL concentration, gross lyophilizate overfill (HPLC purity × net peptide content), and μM molarity.
CJC-1295 without DAC 5mg Lyophilized Peptide Vial
CJC-1295 without DAC (Modified GRF 1-29) as a 5mg lyophilized vial for qualified B2B sourcing, with batch COA, custom fill discussion, and documentation review.
Review specifications, files, and next-step support before requesting samples.
- Confirm the peptide name, CAS, and core specifications
- Check typical applications and document availability
- Use one inquiry path for pricing, files, samples, or project discussion
Key Review Snapshot
Key Review Snapshot
Compare Track A (~5–7 day stock dispatch) vs. Track B (4–6 week custom runs) and 60-day sample credit.
Verify our exhibiting entity (Suzhou Xilin Technology Co., Ltd.), booth photos, and on-site COA/HPLC review.
Why buyers trust WUMO
Real content, documented — not guesswork
In peptide sourcing, chromatographic purity and delivered quantity require separate evaluation. We keep purity and labeling basis distinct on available documentation, so buyers can review analytical parameters for their quoted batch before ordering.
Purity vs quantity distinction
Purity (%) and reported quantity are distinct analytical parameters. Review purity and reported quantity separately, and confirm the labeling and assay basis for the batch proposed for your order.
Batch-specific documents
Batch documentation reflects the specific lot produced. Ask which batch-specific documents are available for the quoted lot, including COA and supporting HPLC or MS records where applicable.
Documented before commitment
Ingredient identity (INCI / CAS), specification sheet, and SDS are available for technical review. Confirm documentation for the batch proposed for your order before purchase.
Documents Available
Documents Available
COA
Batch-specific COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
HPLC purity report
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
MS identity report
Identity confirmation support for documentation review where available.
Request this file through the inquiry path below.
SDS
SDS / MSDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Spec
Product specification sheet
Product or packaging specification reference for quotation alignment.
Request this file through the inquiry path below.
Overview
Overview
B2B Review Guide
B2B Review Guide
Product Overview
Modified GRF (1-29) is supplied as a lyophilized research peptide in a 5mg vial format for qualified B2B sourcing projects. Fill quantity, vial format, packaging, and documentation scope are set per project. This page describes sourcing and analytical documentation only; it does not describe biological action, end-user application, or product performance.
What the trade name does and does not tell you
In the commercial peptide market, Modified GRF (1-29) is commonly listed as “CJC-1295 without DAC”. In the original literature, CJC-1295 refers to the analog carrying a Drug Affinity Complex modification. The two materials are chemically different, and the shortened trade name does not distinguish them.
The practical consequence is that a product title alone does not tell a buyer which molecule is being quoted. Confirm the form on the COA and the mass-spectrometry identity record rather than in the catalogue name. If two suppliers quote very different prices for “CJC-1295”, check first whether they are quoting the same material.
CAS numbering does not settle it either. Catalogue entries for this material carry more than one CAS number in circulation, and the same numbers are sometimes applied to the DAC-modified form. That is why no CAS number is stated on this page — an identity record is the reliable check.
What WUMO Can Supply
- Modified GRF (1-29) lyophilized vials, 5mg fill as standard
- Alternative fill quantities and vial formats by project
- Batch-specific COA with RP-HPLC and MS results for the supplied batch
- Neutral-label or private-label packaging support
- Co-formulated vial discussion — see the CJC-1295 without DAC + Ipamorelin vial
- MOQ, lead time, and phased delivery planning
Quality and Documentation
A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.
Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.
Compliance Note
This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and WUMO does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.
Specification and documentation references
- Lyophilized vial sourcing guide — fill amount, packaging, MOQ and documentation.
- What a 10mg vial actually contains — peptide content, counterion, moisture and excipients.
- How peptide identity is confirmed by mass spectrometry — what an identity record can and cannot establish.
FAQ
Frequently Asked Questions
How do I confirm I am being quoted the non-DAC material?
Ask for the batch COA and the mass-spectrometry identity record before comparing prices. The two materials differ in molecular weight, so an identity record settles the question; a trade name or catalogue CAS number does not.
Why is no CAS number listed on this page?
Because more than one CAS number is in circulation for this material, and the same numbers are sometimes applied to the DAC-modified form. Quoting one would give false precision. Use the identity record instead.
What fill quantities are available?
5mg per vial is the standard fill on this page. Other fill quantities and vial formats are set per project — share your target fill and vial count and it can be confirmed together with MOQ and lead time.
What should I send to get a quotation?
Company and business type, destination market, intended business use, required documentation package, target fill quantity and estimated volume, packaging preference, and required timeline.
Wholesale Distribution & OEM Private Label
Sourcing CJC-1295 without DAC 5mg Lyophilized Peptide Vial for regional distribution or your own brand?
Compare 7-day ready stock (unbranded 100% Type I neutral borosilicate vials in plain white 10-vial kits) against 4–6 week scheduled factory production with 60-day blind-test sample price credit, 20+ flip-off cap colors, standard lot-matched COA + RP-HPLC + LC-MS, and optional project-specified LAL/uniformity QC: see our Regional Distributor Program or Private-Label Vial OEM Service.
Request Pricing, Files, or Samples
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.